Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,040,546
+$57,872 QoQ
Shares Held
5,635
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#1,268
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 81%
Shared 0%
None 19%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rossmore Private Capital holds $82,109,326 across 11 Drug Manufacturers - General names. AMGN ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
100,877 | $25,619,731 | |
| 2 | LLY |
ELI LILLY & Co
|
20,769 | $24,910,963 | |
| 3 | ABBV |
AbbVie Inc.
|
46,722 | $11,757,124 | |
| 4 | MRK |
Merck & Co., Inc.
|
57,121 | $7,340,048 | |
| 5 | AZN |
Astrazeneca PLC
|
37,843 | $7,175,789 | |
| 6 | AMGN |
Amgen Inc
This page
|
5,635 | $2,040,546 | |
| 7 | NVO |
Novo Nordisk A S
|
23,000 | $1,102,620 | |
| 8 | NVS |
Novartis AG
|
4,581 | $717,934 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,040,546 | 5,635 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,982,674 | 5,635 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,854,865 | 5,667 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,261,998 | 4,472 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,131,079 | 4,051 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,230,310 | 3,949 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,037,086 | 3,979 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,291,417 | 4,008 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,252,299 | 4,008 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,139,554 | 4,008 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,154,384 | 4,008 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $1,108,097 | 4,123 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $904,287 | 4,073 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $973,769 | 4,028 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,059,227 | 4,033 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $871,621 | 3,867 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $881,719 | 3,624 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $726,669 | 3,005 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $687,508 | 3,056 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $679,629 | 3,196 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $754,650 | 3,096 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $794,947 | 3,195 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $959,456 | 4,173 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,056,034 | 4,155 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $909,240 | 3,855 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $643,262 | 3,173 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||